| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Emergency department visits among recipients of chronic opioid therapy.
|
Arch Intern Med
|
2010
|
4.73
|
|
2
|
Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.
|
Pain
|
2008
|
4.43
|
|
3
|
Smartphone medication adherence apps: potential benefits to patients and providers.
|
J Am Pharm Assoc (2003)
|
2013
|
3.13
|
|
4
|
Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.
|
Clin J Pain
|
2010
|
2.54
|
|
5
|
Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
|
J Clin Psychiatry
|
2004
|
2.45
|
|
6
|
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
|
Curr Med Res Opin
|
2009
|
1.97
|
|
7
|
Concordance among three self-reported measures of medication adherence and pharmacy refill records.
|
J Am Pharm Assoc (2003)
|
2005
|
1.97
|
|
8
|
Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study.
|
Drug Alcohol Depend
|
2010
|
1.89
|
|
9
|
A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.
|
Value Health
|
2003
|
1.82
|
|
10
|
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
|
Value Health
|
2009
|
1.80
|
|
11
|
Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
|
Value Health
|
2009
|
1.75
|
|
12
|
Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study.
|
J Pain
|
2008
|
1.74
|
|
13
|
Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study.
|
Pain
|
2010
|
1.65
|
|
14
|
An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
|
Med Care
|
2008
|
1.63
|
|
15
|
Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005.
|
Pain Med
|
2009
|
1.38
|
|
16
|
An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study.
|
J Pain Symptom Manage
|
2010
|
1.36
|
|
17
|
Trends in emergency department visits attributable to acetaminophen overdoses in the United States: 1993-2007.
|
Pharmacoepidemiol Drug Saf
|
2011
|
1.34
|
|
18
|
Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001.
|
J Clin Psychiatry
|
2006
|
1.21
|
|
19
|
The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.
|
Clin J Pain
|
2014
|
1.19
|
|
20
|
Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia.
|
Value Health
|
2009
|
1.12
|
|
21
|
Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis.
|
Clin Ther
|
2002
|
1.10
|
|
22
|
A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
|
Curr Med Res Opin
|
2007
|
1.08
|
|
23
|
The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
|
J Manag Care Pharm
|
2013
|
1.03
|
|
24
|
An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
|
Pharmacoepidemiol Drug Saf
|
2005
|
1.02
|
|
25
|
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
|
Psychiatr Serv
|
2010
|
0.98
|
|
26
|
The initial development of the WebMedQual scale: domain assessment of the construct of quality of health web sites.
|
Int J Med Inform
|
2005
|
0.96
|
|
27
|
Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain.
|
J Adolesc Health
|
2012
|
0.96
|
|
28
|
The cost to managed care of managing pulmonary hypertension.
|
J Med Econ
|
2012
|
0.93
|
|
29
|
Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients.
|
Ethn Dis
|
2002
|
0.93
|
|
30
|
Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
|
Am J Cardiovasc Drugs
|
2012
|
0.92
|
|
31
|
Trends in the prescription of opioids for adolescents with non-cancer pain.
|
Gen Hosp Psychiatry
|
2011
|
0.89
|
|
32
|
Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst.
|
J Am Pharm Assoc (2003)
|
2013
|
0.86
|
|
33
|
Prescription-acquired acetaminophen use and the risk of asthma in adults: a case-control study.
|
Ann Pharmacother
|
2012
|
0.86
|
|
34
|
The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs.
|
J Asthma
|
2005
|
0.86
|
|
35
|
Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims.
|
J Manag Care Pharm
|
2012
|
0.85
|
|
36
|
Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.
|
Health Serv Res
|
2011
|
0.84
|
|
37
|
Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
|
Pharmacotherapy
|
2012
|
0.84
|
|
38
|
Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty.
|
Pharmacotherapy
|
2002
|
0.83
|
|
39
|
Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort.
|
Clin Ther
|
2002
|
0.82
|
|
40
|
The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
|
Curr Med Res Opin
|
2007
|
0.81
|
|
41
|
Current and future forecasts of service use and expenditures of Medicaid-eligible schizophrenia patients in the state of Georgia.
|
Schizophr Bull
|
2004
|
0.80
|
|
42
|
Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.
|
Pharmacoepidemiol Drug Saf
|
2015
|
0.79
|
|
43
|
Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients.
|
J Am Pharm Assoc (2003)
|
2016
|
0.78
|
|
44
|
Prescription-acquired acetaminophen use and potential overuse patterns: 2001-2008.
|
Pharmacoepidemiol Drug Saf
|
2011
|
0.78
|
|
45
|
Metabolic monitoring of patients prescribed second-generation antipsychotics.
|
J Psychiatr Pract
|
2013
|
0.77
|
|
46
|
Future employability, a new approach to cost-effectiveness analysis of antipsychotic therapy.
|
Schizophr Res
|
2003
|
0.76
|
|
47
|
Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015.
|
MMWR Morb Mortal Wkly Rep
|
2017
|
0.76
|
|
48
|
Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans.
|
Pain
|
2017
|
0.75
|
|
49
|
Weighing the evidence for pediatric antipsychotic use.
|
Psychiatr Serv
|
2010
|
0.75
|
|
50
|
Opioid use in the management of diabetic peripheral neuropathy (DPN) in a large commercially insured population.
|
Clin J Pain
|
2015
|
0.75
|